Literature DB >> 10611254

HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21.

E Jauniaux1, S Bao, A Eblen, X Li, Z M Lei, S Meuris, C V Rao.   

Abstract

Trisomy 21 is associated with high maternal serum concentrations of intact human chorionic gonadotrophin alpha(HCG) and free beta-HCG whereas these concentrations are markedly decreased in trisomy 18. In this study, we investigated the effect of trisomy 21 and 18 on endogenous HCG concentrations and luteinizing hormone (LH)/HCG receptor expression in placental villous tissue in eight trisomy 21, six trisomy 18 and 42 chromosomally normal samples, collected at 12-16 weeks gestation. The tissue concentrations of intact HCG, free alpha-HCG and free beta-HCG subunits were measured using solid-phase two-site immunoradiometric assay. LH/HCG receptor expression was evaluated with immunohistochemistry and in-situ hybridization. Villous tissue in trisomy 21 contained higher beta-HCG concentrations than the controls (P < 0.05). In trisomy 18 cases, the beta-HCG concentration was lower than in the control group (P < 0.01). Both immunocytochemistry and in-situ hybridization demonstrated a more intense staining of the trophoblast in cases of trisomy 21 and 18, compared with controls with the strongest signal in cases of trisomy 18 (P < 0.01). We concluded that in trisomy 21 the high tissue HCG concentration and expression of LH/HCG receptor in the trophoblast may reflect the relative immaturity of the trophoblastic tissue whereas in trisomy 18, the very low concentration of endogenous HCG, associated with an over-expression of LH/HCG receptor in the trophoblast, is probably secondary to the poor differentiation of the cytotrophoblast.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611254     DOI: 10.1093/molehr/6.1.5

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

1.  Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors.

Authors:  S Brouillet; P Hoffmann; S Chauvet; A Salomon; S Chamboredon; F Sergent; M Benharouga; J J Feige; N Alfaidy
Journal:  Cell Mol Life Sci       Date:  2011-12-03       Impact factor: 9.261

Review 2.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations.

Authors:  Hannu Koistinen; Laura Hautala; Katri Koli; Ulf-Håkan Stenman
Journal:  Mol Endocrinol       Date:  2015-10-23

4.  A toolkit for the application of placental-fetal molecular biomarkers in epidemiologic studies of the fetal origins of chronic disease.

Authors:  Jennifer J Adibi; Alexander J Layden; Qing Yin; Xiaoshuang Xun; Shyamal Peddada; Rahel L Birru
Journal:  Curr Epidemiol Rep       Date:  2020-12-28

Review 5.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

Review 6.  hCG, the wonder of today's science.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2012-03-28       Impact factor: 5.211

7.  A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies.

Authors:  Subhasis Banerjee; Alan Smallwood; Anne E Chambers; Aris Papageorghiou; Hugues Loosfelt; Kevin Spencer; Stuart Campbell; Kypros Nicolaides
Journal:  Reprod Biol Endocrinol       Date:  2005-06-21       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.